Article
Comprehensive multicentre retrospective analysis for predicting isocitrate dehydrogenase-mutant lower-grade gliomas.
Annals of clinical and translational neurology - 1 Feb 2025
Zhao Dongxu, Duan Lin, Juratli Tareq A, Shen Fazheng, Zhou Liyun, Cui Shulin, Zhang Hang, Ren Hang, Cheng Luyao, Wang Hailan, Shi Wenhan, Li Tianxiao, Li Ming
Abstract excerpt
OBJECTIVE: To differentiate glioma grading and determine isocitrate dehydrogenase (IDH) mutation status, which are crucial for prognosis assessment and treatment planning in glioma patients. METHODS: This retrospective study included patients diagnosed with adult diffuse glioma from 1 January, 2018 to 31 July, 2023 in two independent institutions. It documented and analysed clinical and radiographic features. A...
Topics
Join the communities discussing this publication.
